2023 ACI: A Focus on Nurses

Presentation slides and video from the 2023 Advances in Cancer Immunotherapy^™ Series: A Focus on Nurses were presented virtually on May 17, 2023.

Program Organizers

• Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, FAAN – Smilow Cancer Hospital, Yale Cancer Center, Yale School of Nursing
• Beth Sandy, MSN, CRNP – Abramson Cancer Center, University of Pennsylvania
  
  

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

•  Describe the expanding landscape of immune checkpoint immunotherapy.

•  Identify available patient education resources for cancer immunotherapy immune-related adverse events.

•  Distinguish the mechanisms of immune-related adverse reactions from cancer immunotherapy treatment.

•  Recognize and properly triage immune related adverse events related to cancer immunotherapy.

You can view the program agenda here.

Please note continuing education credits are not available for on-demand recordings.